ASTHO Statement on Biden Administration Designating Fentanyl Combined with Xylazine as an Emerging Threat to the United States
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...